Laryngeal cancer cost analysis

Association of case-mix and treatment characteristics with medical charges

David J. Arnold, Gerry F. Funk, Lucy Hynds Karnell, Hung Chih Chen, Henry T. Hoffman, Joan M. Ricks, M. Bridget Zimmerman, Dean P. Corbae, Weining Zhen, Timothy M. McCulloch, Scott M. Graham

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objectives: To examine the relationship of various pretreatment case-mix characteristics and treatment modalities with medical charges incurred during diagnosis, treatment, and 2-year follow-up for patients with laryngeal cancer. Design: Retrospective chart review and billing record analysis. Methods: The charts and billing records of patients diagnosed with laryngeal cancer at the University of Iowa Hospitals and Clinics (UIHC) between January 1, 1991 and December 31, 1994 were reviewed. The independent variables included various pretreatment patient-mix and tumor characteristics (age, AJCC TNM clinical stage, smoking history, ASA class, and comorbidity as defined by Kaplan-Feinstein grade) as well as type of treatment. The dependent variables included total physician, office, and university hospital-based charges incuffed during the pretreatment evaluation and 0- to 3-, 3- to 12-, and 12- to 24-month billing periods after the initiation of cancer-directed therapy. Total 1-year and 2-year charges were also evaluated. Univariate and multivariate analyses were used to investigate the relationships between dependent and independent variables and to develop models predictive of management charges during the individual and total billing periods. Results: Pretreatment charges showed no significant associations (P < .05) with any of the independent variables. Multiple regression analyses indicated that comorbidity, stage, and initial treatment modality were significant variables in one or more of the models predicting charges incurred during the 0- to 3-month, 3- to 12-month, total 1-year, and total 2-year billing periods. The models yielded R2 values for the total 1- and 2-year billing periods of 0.5246 and 0.5055, respectively. Conclusions: This work supports continued study of measures that may result in earlier detection of laryngeal cancer as a potential means of reducing management charges. These results also indicate that a more accurate method of stratifying the disease severity of laryngeal cancer patients for reimbursement purposes would include measurements of the severity of the index disease as well as comorbid diseases.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalLaryngoscope
Volume110
Issue number1
DOIs
StatePublished - Jan 1 2000

Fingerprint

Laryngeal Neoplasms
Diagnosis-Related Groups
Costs and Cost Analysis
Comorbidity
Hospital Charges
Therapeutics
Physicians' Offices
Early Detection of Cancer
Neoplasms
Multivariate Analysis
Smoking
History
Regression Analysis

Keywords

  • Cost analysis
  • Laryngeal cancer

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Arnold, D. J., Funk, G. F., Karnell, L. H., Chen, H. C., Hoffman, H. T., Ricks, J. M., ... Graham, S. M. (2000). Laryngeal cancer cost analysis: Association of case-mix and treatment characteristics with medical charges. Laryngoscope, 110(1), 1-7. https://doi.org/10.1097/00005537-200001000-00001

Laryngeal cancer cost analysis : Association of case-mix and treatment characteristics with medical charges. / Arnold, David J.; Funk, Gerry F.; Karnell, Lucy Hynds; Chen, Hung Chih; Hoffman, Henry T.; Ricks, Joan M.; Zimmerman, M. Bridget; Corbae, Dean P.; Zhen, Weining; McCulloch, Timothy M.; Graham, Scott M.

In: Laryngoscope, Vol. 110, No. 1, 01.01.2000, p. 1-7.

Research output: Contribution to journalArticle

Arnold, DJ, Funk, GF, Karnell, LH, Chen, HC, Hoffman, HT, Ricks, JM, Zimmerman, MB, Corbae, DP, Zhen, W, McCulloch, TM & Graham, SM 2000, 'Laryngeal cancer cost analysis: Association of case-mix and treatment characteristics with medical charges', Laryngoscope, vol. 110, no. 1, pp. 1-7. https://doi.org/10.1097/00005537-200001000-00001
Arnold, David J. ; Funk, Gerry F. ; Karnell, Lucy Hynds ; Chen, Hung Chih ; Hoffman, Henry T. ; Ricks, Joan M. ; Zimmerman, M. Bridget ; Corbae, Dean P. ; Zhen, Weining ; McCulloch, Timothy M. ; Graham, Scott M. / Laryngeal cancer cost analysis : Association of case-mix and treatment characteristics with medical charges. In: Laryngoscope. 2000 ; Vol. 110, No. 1. pp. 1-7.
@article{32e2c22387d44572875f019d51cfd422,
title = "Laryngeal cancer cost analysis: Association of case-mix and treatment characteristics with medical charges",
abstract = "Objectives: To examine the relationship of various pretreatment case-mix characteristics and treatment modalities with medical charges incurred during diagnosis, treatment, and 2-year follow-up for patients with laryngeal cancer. Design: Retrospective chart review and billing record analysis. Methods: The charts and billing records of patients diagnosed with laryngeal cancer at the University of Iowa Hospitals and Clinics (UIHC) between January 1, 1991 and December 31, 1994 were reviewed. The independent variables included various pretreatment patient-mix and tumor characteristics (age, AJCC TNM clinical stage, smoking history, ASA class, and comorbidity as defined by Kaplan-Feinstein grade) as well as type of treatment. The dependent variables included total physician, office, and university hospital-based charges incuffed during the pretreatment evaluation and 0- to 3-, 3- to 12-, and 12- to 24-month billing periods after the initiation of cancer-directed therapy. Total 1-year and 2-year charges were also evaluated. Univariate and multivariate analyses were used to investigate the relationships between dependent and independent variables and to develop models predictive of management charges during the individual and total billing periods. Results: Pretreatment charges showed no significant associations (P < .05) with any of the independent variables. Multiple regression analyses indicated that comorbidity, stage, and initial treatment modality were significant variables in one or more of the models predicting charges incurred during the 0- to 3-month, 3- to 12-month, total 1-year, and total 2-year billing periods. The models yielded R2 values for the total 1- and 2-year billing periods of 0.5246 and 0.5055, respectively. Conclusions: This work supports continued study of measures that may result in earlier detection of laryngeal cancer as a potential means of reducing management charges. These results also indicate that a more accurate method of stratifying the disease severity of laryngeal cancer patients for reimbursement purposes would include measurements of the severity of the index disease as well as comorbid diseases.",
keywords = "Cost analysis, Laryngeal cancer",
author = "Arnold, {David J.} and Funk, {Gerry F.} and Karnell, {Lucy Hynds} and Chen, {Hung Chih} and Hoffman, {Henry T.} and Ricks, {Joan M.} and Zimmerman, {M. Bridget} and Corbae, {Dean P.} and Weining Zhen and McCulloch, {Timothy M.} and Graham, {Scott M.}",
year = "2000",
month = "1",
day = "1",
doi = "10.1097/00005537-200001000-00001",
language = "English (US)",
volume = "110",
pages = "1--7",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Laryngeal cancer cost analysis

T2 - Association of case-mix and treatment characteristics with medical charges

AU - Arnold, David J.

AU - Funk, Gerry F.

AU - Karnell, Lucy Hynds

AU - Chen, Hung Chih

AU - Hoffman, Henry T.

AU - Ricks, Joan M.

AU - Zimmerman, M. Bridget

AU - Corbae, Dean P.

AU - Zhen, Weining

AU - McCulloch, Timothy M.

AU - Graham, Scott M.

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Objectives: To examine the relationship of various pretreatment case-mix characteristics and treatment modalities with medical charges incurred during diagnosis, treatment, and 2-year follow-up for patients with laryngeal cancer. Design: Retrospective chart review and billing record analysis. Methods: The charts and billing records of patients diagnosed with laryngeal cancer at the University of Iowa Hospitals and Clinics (UIHC) between January 1, 1991 and December 31, 1994 were reviewed. The independent variables included various pretreatment patient-mix and tumor characteristics (age, AJCC TNM clinical stage, smoking history, ASA class, and comorbidity as defined by Kaplan-Feinstein grade) as well as type of treatment. The dependent variables included total physician, office, and university hospital-based charges incuffed during the pretreatment evaluation and 0- to 3-, 3- to 12-, and 12- to 24-month billing periods after the initiation of cancer-directed therapy. Total 1-year and 2-year charges were also evaluated. Univariate and multivariate analyses were used to investigate the relationships between dependent and independent variables and to develop models predictive of management charges during the individual and total billing periods. Results: Pretreatment charges showed no significant associations (P < .05) with any of the independent variables. Multiple regression analyses indicated that comorbidity, stage, and initial treatment modality were significant variables in one or more of the models predicting charges incurred during the 0- to 3-month, 3- to 12-month, total 1-year, and total 2-year billing periods. The models yielded R2 values for the total 1- and 2-year billing periods of 0.5246 and 0.5055, respectively. Conclusions: This work supports continued study of measures that may result in earlier detection of laryngeal cancer as a potential means of reducing management charges. These results also indicate that a more accurate method of stratifying the disease severity of laryngeal cancer patients for reimbursement purposes would include measurements of the severity of the index disease as well as comorbid diseases.

AB - Objectives: To examine the relationship of various pretreatment case-mix characteristics and treatment modalities with medical charges incurred during diagnosis, treatment, and 2-year follow-up for patients with laryngeal cancer. Design: Retrospective chart review and billing record analysis. Methods: The charts and billing records of patients diagnosed with laryngeal cancer at the University of Iowa Hospitals and Clinics (UIHC) between January 1, 1991 and December 31, 1994 were reviewed. The independent variables included various pretreatment patient-mix and tumor characteristics (age, AJCC TNM clinical stage, smoking history, ASA class, and comorbidity as defined by Kaplan-Feinstein grade) as well as type of treatment. The dependent variables included total physician, office, and university hospital-based charges incuffed during the pretreatment evaluation and 0- to 3-, 3- to 12-, and 12- to 24-month billing periods after the initiation of cancer-directed therapy. Total 1-year and 2-year charges were also evaluated. Univariate and multivariate analyses were used to investigate the relationships between dependent and independent variables and to develop models predictive of management charges during the individual and total billing periods. Results: Pretreatment charges showed no significant associations (P < .05) with any of the independent variables. Multiple regression analyses indicated that comorbidity, stage, and initial treatment modality were significant variables in one or more of the models predicting charges incurred during the 0- to 3-month, 3- to 12-month, total 1-year, and total 2-year billing periods. The models yielded R2 values for the total 1- and 2-year billing periods of 0.5246 and 0.5055, respectively. Conclusions: This work supports continued study of measures that may result in earlier detection of laryngeal cancer as a potential means of reducing management charges. These results also indicate that a more accurate method of stratifying the disease severity of laryngeal cancer patients for reimbursement purposes would include measurements of the severity of the index disease as well as comorbid diseases.

KW - Cost analysis

KW - Laryngeal cancer

UR - http://www.scopus.com/inward/record.url?scp=0033971050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033971050&partnerID=8YFLogxK

U2 - 10.1097/00005537-200001000-00001

DO - 10.1097/00005537-200001000-00001

M3 - Article

VL - 110

SP - 1

EP - 7

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 1

ER -